Atteinte pulmonaire au cours de la sclérodermie systémique. Partie I. Pneumopathie interstitielle chronique fibrosante

Von Notthafft, 1898, Neue arbeiten und anschihten uber sklerodermia, Zentralbl Allg Pathol Anat, 9, 870 Arroliga, 1992, Pulmonary manifestations of scleroderma, J Thorac Imaging, 7, 30, 10.1097/00005382-199203000-00005 Black, 1996, Organ involvement pulmonary, 299 Geppert, 1990, Southwestern internal medicine conference: Clinical features, pathogenic mechanisms, and new developments in the treatment of systemic sclerosis, Am J Med Sci, 299, 193, 10.1097/00000441-199003000-00009 Marie, 1999, Atteinte pulmonaire au cours de la sclérodermie systémique. Partie II. Hypertension artérielle pulmonaire isolée, cancers, hémorragie alvéolaire, Rev Méd Interne, 20, 1017, 10.1016/S0248-8663(00)87082-4 Marie, 1998, Manometry of the upper intestinal tract in patients with systemic sclerosis. A prospective study, Arthritis Rheum, 41, 1874, 10.1002/1529-0131(199810)41:10<1874::AID-ART21>3.0.CO;2-T Marie, 1999, Atteinte de l'intestin grêle au cours de la sclérodermie systémique, Rev Méd Interne, 20, 504, 10.1016/S0248-8663(99)80085-X Silver, 1990, Lung involvement in systemic sclerosis, Rheum Dis Clin North Am, 16, 199, 10.1016/S0889-857X(21)01049-8 Silver, 1996, Scleroderma. Clinical problems. The lungs, Rheum Dis Clin North Am, 22, 825, 10.1016/S0889-857X(05)70303-3 Simeon, 1997, Survival prognostic factors and markers of morbidity in spanish patients with systemic sclerosis, Ann Rheum Dis, 56, 723, 10.1136/ard.56.12.723 Steen, 1992, Isolated diffusing capacity reduction in systemic sclerosis, Arthritis Rheum, 35, 765, 10.1002/art.1780350709 Steen, 1994, Severe restrictive lung disease in systemic sclerosis, Arthritis Rheum, 37, 1283, 10.1002/art.1780370903 Vallance, 1995, Immunosuppressive treatment of the pulmonary manifestations of progressive systemic sclerosis, Curr Opin Rheumatol, 7, 174, 10.1097/00002281-199505000-00004 Denton, 1997, Comparison of doppler echocardiography and right heart catheterization to assess pulmonary hypertension in systemic sclerosis, Br J Rheumatol, 36, 239, 10.1093/rheumatology/36.2.239 Scully, 1989, Case records of the Massachusetts General Hospital, N Engl J Med, 320, 1333 Stupi, 1986, Pulmonary hypertension in the CREST syndrome variant of systemic sclerosis, Arthritis Rheum, 29, 515, 10.1002/art.1780290409 Ungerer, 1983, Prevalence and clinical correlates of pulmonary arterial hypertension in progressive systemic sclerosis, Am J Med, 75, 65, 10.1016/0002-9343(83)91169-5 Edelson, 1985, Lung inflammation in scleroderma: clinical, radiographic, physiologic and cytopathological features, J Rheumatol, 12, 957 Lee, 1992, Mortality in systemic sclerosis (scleroderma), Q J Med, 82, 139 Wechsler, 1996, The relationship of thoracic lymphadenopathy to pulmonary interstitial disease in diffuse and limited systemic sclerosis: CT findings, AJR, 167, 101, 10.2214/ajr.167.1.8659350 McCarthy, 1988, The lungs in systemic sclerosis (scleroderma). A review and new information, Semin Arthritis Rheum, 17, 271, 10.1016/0049-0172(88)90012-1 Spagnolatti, 1997, Pulmonary function in patients with systemic sclerosis, Monaldi Arch Chest Dis, 52, 4 Steen, 1985, Pulmonary involvement in systemic sclerosis (scleroderma), Arthritis Rheum, 28, 759, 10.1002/art.1780280706 Tuffanelli, 1961, Systemic scleroderma. A clinical study of 727 cases, Arch Dermatol, 84, 359, 10.1001/archderm.1961.01580150005001 Weaver, 1967, The lung in scleroderma, 42, 754 D'Angelo, 1969, Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls, Am J Med, 46, 428, 10.1016/0002-9343(69)90044-8 Hunninghake, 1979, Pulmonary involvement in the collagen vascular diseases, Am Rev Respir Dis, 119, 471 Weaver, 1968, Pulmonary scleroderma, Br J Dis Chest, 54, 490, 10.1378/chest.54.6.490 Lomeo, 1989, Progressive systemic sclerosis sine scleroderma presenting as pulmonary interstitial fibrosis, Am J Med, 87, 525, 10.1016/S0002-9343(89)80608-4 Rodnan, 1962, Progressive systemic sclerosis sine scleroderma, JAMA, 180, 665, 10.1001/jama.1962.03050210027006 Altman, 1991, Predictors of survival in systemic sclerosis (scleroderma), Arthritis Rheum, 34, 403, 10.1002/art.1780340405 De Clerck, 1987, D-penicillamine therapy and interstitial lung disease in scleroderma. A long-term followup study, Arthritis Rheum, 30, 643, 10.1002/art.1780300607 LeRoy, 1988, Scleroderma (systemic sclerosis): classification, subsets and pathogenesis, J Rheumatol, 15, 202 Parent-Woillez, 1997, L'hypertension artérielle pulmonaire primitive: une complication rare, mais souvent mortelle, du CREST syndrome, Rev Méd Interne, 18, 109, 10.1016/S0248-8663(97)84675-9 Peters-Golden, 1984, Clinical and demographic predictors of loss of pulmonary function in systemic sclerosis, Medicine, 63, 221, 10.1097/00005792-198407000-00004 Sfikakis, 1990, Diffusing capacity of the lung and nifedipine in systemic sclerosis, Arthritis Rheum, 33, 1634, 10.1002/art.1780331105 Vayssairat, 1992, Long-term follow-up study of 164 patients with definite systemic sclerosis: classification considerations, Clin Rheum, 11, 356, 10.1007/BF02207193 Steen, 1994, Therapy for severe interstitial lung disease in systemic sclerosis, Arthritis Rheum, 37, 1290, 10.1002/art.1780370904 Steen, 1988, Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis, Arthritis Rheum, 31, 196, 10.1002/art.1780310207 Catoggio, 1983, Serological markers in progressive systemic sclerosis: clinical correlations, Ann Rheum Dis, 42, 23, 10.1136/ard.42.1.23 Manoussakis, 1987, Pulmonary involvement in systemic sclerosis: association with anti-scl 70 antibody and digital pitting, Chest, 92, 509, 10.1378/chest.92.3.509 Martinez-Cordero, 1989, Antinuclear antibodies associated with pulmonary involvement in systemic sclerosis, Chest, 96, 960, 10.1378/chest.96.4.960-b Sato, 1994, Antihistone antibodies in systemic sclerosis: association with pulmonary fibrosis, Arthritis Rheum, 37, 391, 10.1002/art.1780370313 Salerni, 1977, Pulmonary hypertension in the CREST syndrome variant of progressive systemic sclerosis (scleroderma), Ann Intern Med, 86, 394, 10.7326/0003-4819-86-4-394 Steen, 1984, Clinical and laboratory associations of anticentromere antibody in patients with progressive systemic sclerosis, Arthritis Rheum, 27, 125, 10.1002/art.1780270202 Kane, 1996, Lung involvement in systemic sclerosis (scleroderma): relation to classification based on extent of skin involvement or autoantibody status, Resp Med, 90, 223, 10.1016/S0954-6111(96)90291-7 Salojin, 1997, Antiendothelial cell antibodies: useful markers of systemic sclerosis, Am J Med, 102, 178, 10.1016/S0002-9343(96)00404-4 Briggs, 1991, Immunogenetic prediction of pulmonary fibrosis in systemic sclerosis, Lancet, 338, 661, 10.1016/0140-6736(91)91235-M Lynch, 1982, Histocompatibility antigens in progressive systemic sclerosis (scleroderma), J Clin Immunol, 2, 314, 10.1007/BF00915073 Denis, 1981, Esophageal motility and pulmonary function in progressive systemic sclerosis, Respiration, 42, 21, 10.1159/000194399 Lock, 1997, Association of esophageal dysfunction and pulmonary function impairment in systemic sclerosis, Am J Gastroenterol, 93, 341, 10.1111/j.1572-0241.1998.00341.x Haustein, 1998, Silica induced scleroderma — clinical and experimental aspects, J Rheumatol, 25, 1917 Silman, 1991, Epidemiology of scleroderma, Curr Opin Rheumatol, 3, 967, 10.1097/00002281-199112000-00012 Silman, 1992, What is the contribution of occupational environmental factors to the occurrence of scleroderma in men?, Ann Rheum Dis, 51, 1322, 10.1136/ard.51.12.1322 Owens, 1987, Cardiopulmonary manifestations of systemic sclerosis, Chest, 91, 118, 10.1378/chest.91.1.118 Silman, 1988, An epidemiological study of scleroderma in the West Midlands, Br J Rheumatol, 27, 286, 10.1093/rheumatology/27.4.286 Silver, 1993, Cyclophosphamide and low-dose prednisone therapy in patients with systemic sclerosis (scleroderma) with interstitial lung disease, J Rheumatol, 20, 838 Alton, 1988, Lung involvement in scleroderma, 181 Greenwald, 1987, Longitudinal changes in lung function and respiratory symptoms in progressive systemic sclerosis, Am J Med, 83, 83, 10.1016/0002-9343(87)90501-8 Ng, 1990, Bilateral spontaneous pneumothorax in systemic sclerosis. Report of two cases, J Rheumatol, 17, 689 Kim, 1988, Endobronchial telangiectasias and hemoptysis in scleroderma, Am J Med, 84, 173, 10.1016/0002-9343(88)90030-7 Newman, 1988, Hemoptysis secondary to respiratory tract telangiectasias in CREST syndrome, J Rheumatol, 15, 1874 Bjerke, 1979, Small airways in progressive systemic sclerosis, Am J Med, 66, 201, 10.1016/0002-9343(79)90528-X Harrison, 1991, Structural features of interstitial lung disease in systemic sclerosis, Am Rev Respir Dis, 144, 706, 10.1164/ajrccm/144.3_Pt_1.706 Owens, 1983, Pulmonary function in progressive systemic sclerosis: comparison of CREST syndrome variant with diffuse scleroderma, Chest, 84, 546, 10.1378/chest.84.5.546 Kosaka, 1984, Large cystic lesions of the upper lobes of the lungs in two patients with CREST syndrome, Arthritis Rheum, 27, 935, 10.1002/art.1780270814 Harrison, 1989, Pulmonary involvement in systemic sclerosis: the detection of early changes by thin section CT scan, bronchoalveolar lavage and 99m Tc-DTPA clearance, Respir Med, 83, 403, 10.1016/S0954-6111(89)80072-1 Chan, 1997, Cryptogenic fibrosing alveolitis and the fibrosing alveolitis of systemic sclerosis: morphological differences on computed tomographic scans, Thorax, 52, 265, 10.1136/thx.52.3.265 Dévényi, 1995, High resolution computed tomography for the evaluation of lung involvement in 101 patients with scleroderma, Clin Rheumatol, 14, 633, 10.1007/BF02207928 Raghu, 1995, Interstitial lung disease: a diagnostic approach. Are CT Scan and lung biopsy indicated in every patient?, Am J Respir Crit Care Med, 151, 909, 10.1164/ajrccm/151.3_Pt_1.909 Rémy-Jardin, 1993, Pulmonary involvement in progressive systemic sclerosis: sequential evaluation with CT, pulmonary function tests, and bronchoalveolar lavage, Radiology, 188, 499, 10.1148/radiology.188.2.8327704 Schurawitzki, 1990, Interstitial lung disease in progressive systemic sclerosis: high-resolution CT versus radiography, Radiology, 176, 755, 10.1148/radiology.176.3.2389033 Seely, 1998, Systemic sclerosis: using high-resolution CT to detect lung disease in children, AJR, 170, 691, 10.2214/ajr.170.3.9490955 Warrick, 1991, High resolution computed tomography in early scleroderma lung disease, J Rheumatol, 18, 1520 Wells, 1993, The predictive value of appearances on thin-section computed tomography in fibrosing alveolitis, Am Rev Respir Dis, 148, 1076, 10.1164/ajrccm/148.4_Pt_1.1076 Wells, 1997, Fibrosing alveolitis in systemic sclerosis. Indices of lung function in relation to extent of disease on computed tomography, Arthritis Rheum, 40, 1229, 10.1002/1529-0131(199707)40:7<1229::AID-ART6>3.0.CO;2-W Muir, 1997, Organizing diffuse alveolar damage associated with progressive systemic sclerosis, 72, 639 Muller, 1987, Fibrosing alveolitis: CT-pathologic correlation, Radiology, 165, 731, 10.1148/radiology.165.3.3685351 Murata, 1988, Optimization of computed tomography technique to demonstrate the fine structure of the lung, Invest Radiol, 23, 170, 10.1097/00004424-198803000-00003 Michon-Pasturel, 1997, Étude séquentielle scanographique du poumon sclérodermique, Rev Méd Interne, 18, 460S, 10.1016/S0248-8663(97)80186-5 Wells, 1992, High resolution computed tomography as a predictor of lung histology in systemic sclerosis, Thorax, 47, 738, 10.1136/thx.47.9.738 Wells, 1994, Fibrosing alveolitis associated with systemic sclerosis has a better prognosis than lone cryptogenic fibrosing alveolitis, Am J Respir Crit Care Med, 149, 1583, 10.1164/ajrccm.149.6.8004317 Bhalla, 1993, Chest CT in patients with scleroderma: prevalence of asymptomatic esophageal dilatation and mediastinal lymphadenopathy, AJR, 161, 269, 10.2214/ajr.161.2.8333359 Garber, 1992, Enhanced mediastinal lymph modes in the fibrosing alveolitis of systemic sclerosis, Br J Radiol, 65, 983, 10.1259/0007-1285-65-779-983 Wells, 1993, Serial CT in fibrosing alveolitis: prognostic significance of the initial pattern, AJR, 161, 1159, 10.2214/ajr.161.6.8249719 Wells, 1997, Functional impairment in fibrosing alveolitis: relationship to reversible disease on thin section computed tomography, Eur Respir J, 10, 280, 10.1183/09031936.97.10020280 Akesson, 1989, Organ manifestations in 100 patients with progressive systemic sclerosis: a comparison between the CREST syndrome and diffuse scleroderma, Br J Rheumatol, 28, 281, 10.1093/rheumatology/28.4.281 Akesson, 1994, Improved pulmonary function in systemic sclerosis after treatment with cyclophosphamide, Arthritis Rheum, 37, 729, 10.1002/art.1780370518 Guttadauria, 1977, Pulmonary function in scleroderma, Arthritis Rheum, 20, 1071, 10.1002/art.1780200506 Jacobsen, 1997, A longitudinal study of pulmonary function in danish patients with systemic sclerosis, Clin Rheumatol, 16, 384, 10.1007/BF02242456 Bagg, 1979, Serial pulmonary function tests in progressive systemic sclerosis, Thorax, 34, 224, 10.1136/thx.34.2.224 Dujic, 1994, Increase of pulmonary diffusing capacity in systemic sclerosis, Br J Rheumatol, 33, 437, 10.1093/rheumatology/33.5.437 Schwaiblmair, 1996, Cardiorespiratory responses to incremental exercise in patients with systemic sclerosis, Chest, 110, 1520, 10.1378/chest.110.6.1520 Cherniack, 1995, Correlation of structure and function in idiopathic pulmonary fibrosis, Am J Respir Crit Care Med, 151, 1180 Wells, 1997, Functional impairment in lone cryptogenic fibrosing alveolitis and fibrosing alveolitis associated with systemic sclerosis. A comparison, Am J Respir Crit Care Med, 155, 1657, 10.1164/ajrccm.155.5.9154872 Behr, 1995, Pathogenetic and clinical significance of fibroblast activation in scleroderma lung disease, Respiration, 62, 209, 10.1159/000196449 Miller, 1990, Lung disease associated with progressive systemic sclerosis. Assessment of interlobar variation by bronchoalveolar lavage and comparison with noninvasive evaluation of disease activity, Am Rev Respir Dis, 141, 301, 10.1164/ajrccm/141.2.301 Owens, 1986, Role of inflammation in the lung disease of systemic sclerosis: comparison with idiopathic pulmonary fibrosis, J Lab Clin Med, 107, 253 Silver, 1990, Evaluation and management of scleroderma lung disease using bronchoalveolar lavage, Am J Med, 88, 470, 10.1016/0002-9343(90)90425-D Wallaert, 1986, Subclinical pulmonary involvement in collagen vascular diseases assessed by bronchoalveolar lavage. Relationship between alveolitis and subsequent changes in lung function, Am Rev Respir Dis, 133, 574 Domogala-Kulawik, 1997, Lymphocyte phenotyping in systemic sclerosis. A flow cytometry analysis of lymphocytes in bronchoalveolar lavage fluid, Anal Quant Cytol Histol, 19, 264 Silver, 1995, Interstitial lung disease of systemic sclerosis, Intern Rev Immunol, 12, 281, 10.3109/08830189509056718 Rossi, 1985, Evidence for chronic inflammation as a component of the interstitial lung disease associated with progressive systemic sclerosis, Am Rev Respir Dis, 131, 612, 10.1164/arrd.1985.131.4.612 Cailes, 1996, Neutrophil activation in fibrosing alveolitis: a comparison of lone cryptogenic fibrosing alveolitis and systemic sclerosis, Eur Respir J, 9, 992, 10.1183/09031936.96.09050992 Harrisson, 1992, Treatment of lung disease in systemic sclerosis: a clinical comparison of responders and non-responders, Am Rev Respir Dis, 145, A755 Rudd, 1981, Cryptogenetic fibrosing alveolitis, Am Rev Respir Dis, 124, 1 Silver, 1986, Interstitial lung disease in scleroderma. Immune complexes in sera and bronchoalveolar lavage fluid, Arthritis Rheum, 29, 525, 10.1002/art.1780290410 Odoux, 1997, Endothelin-1. Secretion by alveolar macrophages in systemic sclerosis, Am J Respir Crit Care Med, 156, 1429, 10.1164/ajrccm.156.5.96-11004 Bolster, 1997, Cytokine concentration in bronchoalveolar lavage fluid of patients with systemic sclerosis, Arthritis Rheum, 40, 743, 10.1002/art.1780400422 Ludwicka, 1995, Elevated levels of platelet derived growth factor and transforming growth factor-β1 in bronchoalveolar lavage fluid from patients with scleroderma, J Rheumatol, 22, 1876 Wells, 1993, Clearance of inhaled 99m-Tc DTPA predicts the clinical course of fribrosing alveolitis, Eur Respir J, 6, 797, 10.1183/09031936.93.06060797 Hoorelbeke, 1991, Évaluation de la scintigraphie de perméabilité alvéolaire et intestinale dans la sclérodermie [thèse], Lille Richard, 1998, Abnormal uptake of Tc-99m MIBI, a novel myocardial imaging agent, in the lungs of patients with systemic sclerosis, Clin Nucl Med, 23, 19, 10.1097/00003072-199801000-00007 Al-Sabbagh, 1989, Pulmonary arterial histology and morphometry in systemic sclerosis: a case-control autopsy study, J Rheumatol, 16, 1038 Abraham, 1997, Increased levels of endothelin-1 and differential endothelin type A and B receptor expression in scleroderma-associated fibrotic lung disease, Am J Pathol, 151, 831 Diot, 1995, Predictive value of serum III procollagen for diagnosis of pulmonary involvement in patients with scleroderma, Eur Respir J, 8, 1559, 10.1183/09031936.95.08091559 Avila, 1999, Fibronectin gene polymorphisms associated with fibrosing alveolitis in systemic sclerosis, Am J Respir Cell Mol Biol, 20, 106, 10.1165/ajrcmb.20.1.3232 Lally, 1988, Progressive systemic sclerosis: mode of presentation, rapidly progressive disease course, and mortality based on an analysis of 91 patients, Semin Arthritis Rheum, 18, 1, 10.1016/0049-0172(88)90030-3 Pope, 1996, Scleroderma. Treatment of systemic sclerosis, Rheum Dis Clin North Am, 22, 893, 10.1016/S0889-857X(05)70307-0 Silman, 1997, Scleroderma — Demographics and survival, J Rheumatol, 24, 58 Steen, 1998, Clinical manifestations of systemic sclerosis, Semin Cut Med Surg, 17, 48, 10.1016/S1085-5629(98)80062-X Medsger, 1971, Survival with systemic sclerosis (scleroderma). A life-table analysis of clinical and demographic factors in 309 patients, Ann Intern Med, 75, 369, 10.7326/0003-4819-75-3-369 Medsger, 1971, Epidemiology of systemic sclerosis (scleroderma), Ann Intern Med, 74, 714, 10.7326/0003-4819-74-5-714 Steen, 1990, Natural history of severe pulmonary fibrosis (SSc) [abstract], Arthritis Rheum, 33, S157 Black, 1990, Systemic sclerosis: is there a treatment yet, Ann Rheum Dis, 49, 735, 10.1136/ard.49.9.735 Steen, 1997, The value of the health assessment questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time, Arthritis Rheum, 40, 1984, 10.1002/art.1780401110 Furst, 1989, Immunosuppression with chlororambucil, versus placebo, for scleroderma: results of a three-year parallel, randomized, double-blind study, Arthritis Rheum, 32, 584, 10.1002/anr.1780320512 Akesson, 1992, Long-term evaluation of D-penicillamine of cyclofenil in systemic sclerosis, Scand J Rheumatol, 21, 238, 10.3109/03009749209099231 Schwartz, 1997, Extracorporeal photochemotherapy in progressive systemic sclerosis: a follow-up study, Int J Dermatol, 36, 380, 10.1046/j.1365-4362.1997.00066.x Steen, 1985, The effect of D-penicillamine on pulmonary findings in systemic sclerosis, Arthritis Rheum, 28, 882, 10.1002/art.1780280807 Bröll, 1976, Zur Behandlung der Interstitiellen Lungenfibrose mit D-Penicillamin bei progressiver Sklerodermie (Langzeitstudie), Wien Klin Wochenschr, 88, 292 Goodman, 1981, Pilot study of penicillamine therapy in steroid failure patients with interstitial lung disease, 291 Turner-Warwick, 1987, The value of serial bronchoalveolar lavages in assessing the clinical progress of patients with cryptogenic fibrosing alveolitis, Am Rev Respir Dis, 135, 26 Steen, 1998, Case-control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis, Arthritis Rheum, 41, 1613, 10.1002/1529-0131(199809)41:9<1613::AID-ART11>3.0.CO;2-O Kyndt, 1998, Traitement par bolus de cyclophosphamide de l'atteinte interstitielle pulmonaire de la sclérodermie systémique, Rev Méd Interne, 19, 406S, 10.1016/S0248-8663(98)90079-0 Varai, 1998, A pilot study of intermittent intravenous cyclophosphamide for the treatment of systemic sclerosis associated lung disease, J Rheumatol, 25, 1325 Winterbauer, 1978, Diffuse interstitial pneumonitis: clinicopathologic correlations in 20 patients treated with prednisone/azathioprine, Am J Med, 656, 661, 10.1016/0002-9343(78)90855-0